.Liquidity Analysis Quarterly Data
Difficulty: Beginner
Liquidity ratios measure the company's ability to meet its short-term obligations.
Ratios (Summary)
Regeneron Pharmaceuticals Inc., liquidity ratios (quarterly data)
| Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | Current ratio | |||||||||||||||||||||
| | Quick ratio | |||||||||||||||||||||
| | Cash ratio |
| Ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s current ratio improved from Q3 2017 to Q4 2017 but then deteriorated significantly from Q4 2017 to Q1 2018. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s quick ratio improved from Q3 2017 to Q4 2017 but then deteriorated significantly from Q4 2017 to Q1 2018. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s cash ratio improved from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018. |
Current Ratio
Regeneron Pharmaceuticals Inc., current ratio calculation (quarterly data)
| Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||||||||||||||||||
| | Current assets | |||||||||||||||||||||
| | Current liabilities | |||||||||||||||||||||
| Ratio | ||||||||||||||||||||||
| | Current ratio1 | |||||||||||||||||||||
Q1 2018 Calculations
1 Current ratio = Current assets ÷ Current liabilities
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s current ratio improved from Q3 2017 to Q4 2017 but then deteriorated significantly from Q4 2017 to Q1 2018. |
Quick Ratio
Regeneron Pharmaceuticals Inc., quick ratio calculation (quarterly data)
| Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||||||||||||||||||
| | Cash and cash equivalents | |||||||||||||||||||||
| | Marketable securities | |||||||||||||||||||||
| | Accounts receivable, trade, net | |||||||||||||||||||||
| | Accounts receivable from Sanofi | |||||||||||||||||||||
| | Accounts receivable from Bayer | |||||||||||||||||||||
| | Total quick assets | |||||||||||||||||||||
| | Current liabilities | |||||||||||||||||||||
| Ratio | ||||||||||||||||||||||
| | Quick ratio1 | |||||||||||||||||||||
Q1 2018 Calculations
1 Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s quick ratio improved from Q3 2017 to Q4 2017 but then deteriorated significantly from Q4 2017 to Q1 2018. |
Cash Ratio
Regeneron Pharmaceuticals Inc., cash ratio calculation (quarterly data)
| Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||||||||||||||||||
| | Cash and cash equivalents | |||||||||||||||||||||
| | Marketable securities | |||||||||||||||||||||
| | Total cash assets | |||||||||||||||||||||
| | Current liabilities | |||||||||||||||||||||
| Ratio | ||||||||||||||||||||||
| | Cash ratio1 | |||||||||||||||||||||
Q1 2018 Calculations
1 Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Regeneron Pharmaceuticals Inc.'s cash ratio improved from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018. |
